350 related articles for article (PubMed ID: 16762115)
21. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti.
Mathieu E; Lammie PJ; Radday J; Beach MJ; Streit T; Wendt J; Addiss DG
Ann Trop Med Parasitol; 2004 Oct; 98(7):703-14. PubMed ID: 15509424
[TBL] [Abstract][Full Text] [Related]
23. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
Ramaiah KD; Vanamail P; Das PK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
[TBL] [Abstract][Full Text] [Related]
24. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
[TBL] [Abstract][Full Text] [Related]
25. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance.
Babu BV; Mishra S
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125
[TBL] [Abstract][Full Text] [Related]
26. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Vanamail P; Ramaiah KD; Subramanian S; Pani SP; Yuvaraj J; Das PK
Ann Trop Med Parasitol; 2005 Apr; 99(3):237-42. PubMed ID: 15829133
[TBL] [Abstract][Full Text] [Related]
27. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
[TBL] [Abstract][Full Text] [Related]
28. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
29. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
Ramaiah KD; Ravi R; Das PK
Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
[No Abstract] [Full Text] [Related]
30. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka.
Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND
Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248
[TBL] [Abstract][Full Text] [Related]
31. COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA.
Kisoka WJ; Tersbøl BP; Meyrowitsch DW; Simonsen PE; Mushi DL
J Biosoc Sci; 2016 Jan; 48(1):94-112. PubMed ID: 25790081
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.
Ramaiah KD; Vijay Kumar KN; Chandrakala AV; Augustin DJ; Appavoo NC; Das PK
Trop Med Int Health; 2001 Dec; 6(12):1062-9. PubMed ID: 11737843
[TBL] [Abstract][Full Text] [Related]
33. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
[TBL] [Abstract][Full Text] [Related]
34. Mass drug administration to eliminate lymphatic filariasis in India.
Ramaiah KD; Das PK
Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
[TBL] [Abstract][Full Text] [Related]
35. Rural-urban population movement, community context and impact on DEC fortified salt program to eliminate lymphatic filariasis.
Nandha B; Krishnamoorthy K
J Commun Dis; 2011 Jun; 43(2):97-103. PubMed ID: 23785866
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic filariasis in India: epidemiology and control measures.
Raju K; Jambulingam P; Sabesan S; Vanamail P
J Postgrad Med; 2010; 56(3):232-8. PubMed ID: 20739779
[TBL] [Abstract][Full Text] [Related]
37. Elimination of lymphatic filariasis in Southeast Asia.
Sudomo M; Chayabejara S; Duong S; Hernandez L; Wu WP; Bergquist R
Adv Parasitol; 2010; 72():205-33. PubMed ID: 20624533
[TBL] [Abstract][Full Text] [Related]
38. Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India.
Sabesan S; Krishnamoorthy K; Hoti SL; Subramanian S; Srividya A; Roy N; Jain T; Kumar A; Rahi M
Indian J Med Res; 2022 Mar; 155(3&4):347-355. PubMed ID: 36124509
[TBL] [Abstract][Full Text] [Related]
39. Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
Maroto-Camino C; Hernandez-Pastor P; Awaca N; Safari L; Hemingway J; Massangaie M; Whitson D; Jeffery C; Valadez JJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007337. PubMed ID: 31276494
[TBL] [Abstract][Full Text] [Related]
40. India tackles lymphatic filariasis.
Bagcchi S
Lancet Infect Dis; 2015 Apr; 15(4):380. PubMed ID: 25809895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
